Abstract
The high incidence of multidrug-resistant (MDR) bacteria among patients admitted to ICUs has determined an increase of tigecycline (TGC) use for the treatment of severe infections. Many concerns have been raised about the efficacy of this molecule and increased dosages have been proposed. Our purpose is to investigate TGC safety and efficacy at higher than standard doses.
| Original language | English |
|---|---|
| Pages (from-to) | R90-R90 |
| Number of pages | 9 |
| Journal | Critical Care |
| Volume | 18 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2014 |
All Science Journal Classification (ASJC) codes
- Critical Care and Intensive Care Medicine
Keywords
- tygecicline
Fingerprint
Dive into the research topics of 'High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver